Atlas Trials

Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

RecordFirmDate
Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum (NCT06040346)Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd2024-04-26
Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19 (NCT05679479)Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd2024-01-19
Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19 (NCT05679492)Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd2023-05-30
To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19 (NCT05813587)Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd2023-03-23
Clinical Study of Meplazumab to Treat With Malaria (NCT04327310)Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd2023-03-01
the Safety and Efficacy of Meplazumab in Patients With COVID-19 (NCT05113784)Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd2022-01-21
Study to Assess the Effect of Meplazumab on COVID-19 (NCT04586153)Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd2021-02-15

Track Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd automatically

Every clearance here is in the API, with alerts when new ones post.